News
With political action underway through an executive order from President Donald Trump and pharmaceutical industry shifts emerging, the question remains whether these changes will lead to sustained ...
As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.
Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...
Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Everything from a live-action Disney remake to the newest Mission Impossible movie will be hitting screens this summer.
Demonstrators protest outside the Center for Disease Control, in Atlanta, after the Trump administration began mass layoffs of 10,000 staffers at U.S. health agencies under the Department of ...
The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results